Perrigo’s Cetirizine syrup is comparable to McNeil Consumer Healthcare’s Zyrtec syrup, 1mg/mL, indicated for the relief of symptoms associated with seasonal allergic rhinitis.
Joseph Papa, chairman and CEO of Perrigo, said: “This approval reflects both our strategy to be first to market with important products and the unique position of the company both in front of and behind the pharmacy counter. This product will join our line of Cetirizine tablets, Cetirizine D and Cetirizine over-the-counter syrup.”